View Item 

Show simple item record

Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma
dc.contributor.authorHayes, Michael J.en_US
dc.contributor.authorCarey, John L.en_US
dc.contributor.authorKrauss, John C.en_US
dc.contributor.authorHedstrom, Deborah L.en_US
dc.contributor.authorGulbranson, Ronald L.en_US
dc.contributor.authorKeren, David F.en_US
dc.date.accessioned2010-06-01T21:32:58Z
dc.date.available2010-06-01T21:32:58Z
dc.date.issued2007-04en_US
dc.identifier.citationHayes, Michael J.; Carey, John L.; Krauss, John C.; Hedstrom, Deborah L.; Gulbranson, Ronald L.; Keren, David F. (2007). "Low IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myeloma." European Journal of Haematology 78(4): 353-357. <http://hdl.handle.net/2027.42/74602>en_US
dc.identifier.issn0902-4441en_US
dc.identifier.issn1600-0609en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/74602
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17378894&dopt=citationen_US
dc.format.extent523785 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2007 The Authors Journal compilation 2007 Blackwell Munksgaarden_US
dc.subject.otherImmunoglobulin Een_US
dc.subject.otherMultiple Myelomaen_US
dc.subject.otherImmunofixationen_US
dc.subject.otherBence Jones Proteinen_US
dc.subject.otherCapillary Zone Electrophoresisen_US
dc.titleLow IgE monoclonal gammopathy level in serum highlights 20-yr survival in a case of IgE multiple myelomaen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelOncology and Hematologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, The University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationotherDepartment of Pathology, Henry Ford Hospital, Detroit, MIen_US
dc.contributor.affiliationotherDepartment of Internal Medicine, St Joseph Mercy Hospital, Ann Arbor, MIen_US
dc.contributor.affiliationotherWarde Medical Laboratory, Ann Arbor, MI, USAen_US
dc.identifier.pmid17378894en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/74602/1/j.1600-0609.2007.00825.x.pdf
dc.identifier.doi10.1111/j.1600-0609.2007.00825.xen_US
dc.identifier.sourceEuropean Journal of Haematologyen_US
dc.identifier.citedreferenceJako JM, Gesztesi T, Kaszas I. IgE lambda monoclonal gammopathy and amyloidosis. Int Arch Allergy Immunol 1997; 112: 415 – 21.en_US
dc.identifier.citedreferenceIshizaka K, Ishizaka T, Hornbrook MM. Physicochemical proteins of reaginic antibody.V. Correlation of reaginic activity with gamma E globulin antibody. J Immunol 1966; 97: 840 – 53.en_US
dc.identifier.citedreference3. Editorial IgE immunoglobulin. Br Med J 1973; 4: 250 – 1.en_US
dc.identifier.citedreferenceOgawa M, Kochwa S, Smith C, Ishizaka K, McIntyre OR. Clinical aspects of IgE myeloma. N Engl J Med 1969; 281: 1217 – 20.en_US
dc.identifier.citedreferenceChusid MJ, Rock AL, Sty JR, Oechler HW, Beste DJ. Kimura's disease: an unusual cause of cervical tumour. Arch Dis Child 1997; 77: 153 – 4.en_US
dc.identifier.citedreferenceJohansson SGO, Bennich H. Immunological studies of an atypical (myeloma) immunoglobulin. Immunology 1967; 13: 381 – 94.en_US
dc.identifier.citedreferenceAllevato PA, Deegan MJ, Chu JW, Perry MB, Barth, CL. A case of IgE myeloma: methodology and review of the literature. Henry Ford Hosp Med J 1984; 32: 134 – 41.en_US
dc.identifier.citedreferenceKairemo KJA, Lindberg M, Prytz M. IgE myeloma: a case presentation and review of the literature. Scand J Clin Lab Invest 1999; 59: 451 – 6.en_US
dc.identifier.citedreferenceLudwig H, Vormittag W. ‘‘Benign’’ monoclonal IgE gammopathy. Br Med J 1980; 23: 539 – 40.en_US
dc.identifier.citedreferenceAlexander RL, Stanford TR, Petruska PJ, Tsai CC, Janney CG. A new case of IgE myeloma. Clin Chem 1992; 38: 2328 – 32.en_US
dc.identifier.citedreferenceMacro M, Andre I, Comby E, Cheze S, Chapon F, Ballet JJ, Reman O, Leporrier M, Troussard X. IgE multiple myeloma. Leuk Lymphoma 1999; 32: 597 – 603.en_US
dc.identifier.citedreferenceVladutiu AO, Kohli RK, Prezyna AP. Monoclonal IgE with renal failure. Am J Med 1976; 61: 957 – 62.en_US
dc.identifier.citedreferenceProctor SJ, Chawla SL, Bird AG, Stephenson J. Hyperviscosity syndrome in IgE myeloma. Br Med J 1984; 289: 1112.en_US
dc.identifier.citedreferenceBemelmans RHH, van Toorn DW, van Leeuwen L, Schaar CG. Long-term complete remission in IgD-myeloma. Eur J Haematol 2006; 76: 339 – 41.en_US
dc.identifier.citedreferenceGrogan TM, MÜller-Hermelink HK, Van Camp B, Harris NL, Kyle RA. Plasma cell neoplasms. In: Jaffe ES, Harris NL, Stein H, Vardiman J, eds. World Health Organization Classification of Tumours: Pathology and Genetics: Tumours of Haematopoetic and Lymphoid Tissues. Lyon: IARC Press, 2000: 142 – 56.en_US
dc.identifier.citedreferenceBakshi NA, Bulbranson R, Garstka D, Bradwell AR, Keren DF. Serum free light chain (FLC) measurement can aid capillary zone electrophoresis in detecting subtle FLC-producing M proteins. Am J Clin Pathol 2005; 124: 214 – 8.en_US
dc.identifier.citedreferenceDurie BGM, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the scientific advisors of the International Myeloma Foundation. Hematol J 2003; 4: 379 – 98.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-0609.2007.00825.x.pdf
Size:
511.5KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.